Moxifloxacin PCD Pharma Franchise Company
Cafoli Lifecare offers 25 Moxifloxacin formulations spanning tablets, injection, eye drops, ear drops, eye ointment and eye/ear drops. All products are manufactured at WHO-GMP certified facilities and offered to franchise partners with monopoly rights.
What is Moxifloxacin?
Moxifloxacin is a fourth-generation fluoroquinolone antibiotic. It inhibits bacterial DNA gyrase and topoisomerase IV, halting DNA replication, and has broad-spectrum activity covering Gram-positive, Gram-negative, atypical and many anaerobic organisms. Details are available on MedlinePlus.
Therapeutic Applications
Systemic Moxifloxacin is used for community-acquired pneumonia, acute bacterial sinusitis, exacerbations of chronic bronchitis, skin and intra-abdominal infections, and as part of drug-resistant TB regimens. Ophthalmic Moxifloxacin is used for bacterial conjunctivitis and post-operative prophylaxis. Prescribers include chest physicians, general physicians, surgeons, ophthalmologists and ENT specialists.
Why Moxifloxacin is a High-Potential Molecule for Distributors
Few antibiotics let a single partner sell into respiratory, surgical, ophthalmology and ENT practice at once. Moxifloxacin eye drops are routine prophylaxis around cataract surgery — one of the highest-volume surgical procedures in India — which creates reliable institutional demand that is largely independent of the seasonal ups and downs of oral antibiotic sales.
Why Choose Cafoli Lifecare
Cafoli provides district-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved formulations, attractive net rates and complete promotional inputs, with 1000+ partners across India.
References
- MedlinePlus: Moxifloxacin
- WHO Essential Medicines List
- PubChem: Moxifloxacin
Our formulations of Moxifloxacin find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: